Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
Mean Cell Volume (MCV) measures the average size of red blood cells. When performed on cord blood, it reflects your newborn’s red blood cell size at birth using a sample collected from the umbilical cord immediately after delivery. The measurement is produced by an automated blood analyzer as part of the red cell indices.
In many settings, MCV from cord blood is included with a complete blood count for the newborn. It helps establish a baseline picture of red blood cell characteristics right at birth, before feeding patterns, environmental factors, or later illnesses can change them.
Red blood cell size gives clues about how the body is making blood and whether nutrients needed for red blood cell production are adequate. In a newborn, MCV can help your care team consider conditions such as iron deficiency, vitamin B12 or folate deficiency, blood loss, hemolysis, or inherited red blood cell disorders. It is usually interpreted together with hemoglobin, hematocrit, red cell distribution width, and a blood smear.
Clinicians may order cord blood MCV as part of routine newborn assessment in some hospitals or when there are risk factors, such as maternal anemia, certain medications, prematurity, or concerns about blood loss around delivery. Understanding MCV can guide whether additional tests or nutritional support are needed for your baby.
Your baby’s result will be compared with newborn-specific expectations for the first days of life. Newborns naturally have different red blood cell characteristics than older children and adults, so your care team will use age-appropriate interpretation. They will also consider the pregnancy and delivery history, feeding plans, and other lab results.
A higher-than-expected MCV can be seen with reticulocytosis, vitamin B12 or folate deficiency, or after significant blood loss and recovery. A lower-than-expected MCV can suggest iron deficiency or certain inherited conditions that affect hemoglobin production. If a result is outside the expected range, your clinician may repeat testing, review a peripheral smear, or check iron studies, vitamin levels, or markers of hemolysis. Many findings simply prompt watchful follow-up rather than urgent treatment.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Differences between cord vein and artery samples, as well as timing relative to cord clamping, can subtly influence red cell measurements and MCV.
Prolonged time in the collection tube or improper mixing with anticoagulant can alter cell size, leading to spurious changes in MCV.
Preterm infants and those with growth restriction can have different red blood cell characteristics, which may affect interpretation of MCV.
Maternal iron deficiency, B12 or folate deficiency, diabetes, hypertension, or smoking can influence the newborn’s red blood cell indices.
Intrauterine or peripartum transfusion, placental abruption, or fetomaternal hemorrhage can change red cell size patterns at birth.
Maternal antiepileptics, folate antagonists, or inadequate prenatal supplementation can impact newborn MCV by affecting red cell production.
References